Swiss site for API maker Cerbios combines chemical and biological R&D

17-Apr-2014 - Swiss high potency active pharmaceutical ingredient (API) contractor Cerbios has broken ground on a building that will bring together its chemical and biological R&D departments.

Albemarle to sell ibuprofen business to SI Group

17-Apr-2014 - Albemarle has agreed to sell its ibuprofen business to US chemical intermediates firm SI Group in a deal that will also see it divest the anaesthetic agent, propofol.

Anti social? Big Pharma balks at US FDA social media guidance

17-Apr-2014 - Comments from Novartis, Eli Lilly and Pfizer revealed that industry is taking serious issue with some aspects of the draft guidance from the US FDA on social media and promotional materials online.

Amine goldmine: BASF commits to new plant citing growing demand

16-Apr-2014 - The amines market will grow 5% over the next decade according to BASF, which cited rising drugmaker demand as a key driver for its investment in a new German plant.

Discovery of tampered vials leads to Roche cancer drug recall

16-Apr-2014 - Roche has recalled nine batches of breast cancer drug Herceptin after tampered vials were discovered in the UK, Finland and Germany.

Thermo Fisher: new pumps compatible with all bioprocessing techs

16-Apr-2014 - Thermo Fisher has launched a pump technology designed for applications across the bioprocessing production line and usable with "all" bioprocessing tech.

Pfizer cold on Viagra-laced ice cream idea

15-Apr-2014 - Pfizer has reminded the creator of Viagra-flavoured ice cream that the blockbuster erectile dysfunction treatment should only be available on prescription.

Hovione gets US patent for simple, patient-inspired inhaler

15-Apr-2014 - Hovione has obtained a US patent for a cheap capsule-based dry powder inhaler that it claims is cheaper for manufacturers to produce and easier for patients to use.

Novartis eyes Asian market with $160m Singapore ophthalmic plant

15-Apr-2014 - Novartis subsidiary Alcon has opened the doors to its new $160m facility in Singapore for the manufacture of ophthalmic drugs.

Acura pays Pfizer $2m to buy back anti-abuse tech and relaunch Oxecta drug

15-Apr-2014 - Acura has reacquired the rights to its opioid abuse-deterrent technology from Pfizer and is looking for pharma partners to relaunch its oxycodone HCL drug Oxecta.

USCC: making sure Chinese APIs are safe is “hopeless task” for US FDA

14-Apr-2014 - Inspecting the thousands of Chinese factories making APIs for the US market is a “hopeless task” even if the FDA gets the extra staff it wants according to a Congressional committee review.

Sugar in place of APIs discovered in EU's largest fake drug seizure

14-Apr-2014 - Fake aspirin and anti-diarrhoeal medicines were amongst the largest counterfeit drugs haul discovered to be destined for the European Union, a French customs official says.

EMA requests more stability data for some manufacturing changes

14-Apr-2014 - Drugmakers in the EU making changes to their manufacturing processes will have to submit additional stability data, according to a new EMA (European Medicines Agency) guideline.

Pfizer MD heads up ABPI, Kay Holcombe joins BIO, and other jobs news

14-Apr-2014 - New appointments at biopharma and equipment companies also feature in this week's column.

Canton Labs hit with US FDA Import Alert at Indian API plant

11-Apr-2014 - The US FDA has banned imports of drug products made at Canton Laboratories’ Baroda, India plant weeks after the plant was pulled up for data failures.

Tamiflu spat: Roche ‘disingenuous,’ say review authors

10-Apr-2014 - Roche has clashed with the authors of a report slamming the efficacy of Tamiflu, each claiming the other’s analysis of patient data is seriously flawed.

Neuland opens new facility in India as part of deal with Japanese company

10-Apr-2014 - CMO Neuland Laboratories has opened a new manufacturing facility in Hyderabad, India as part of its collaboration with Tokyo-based API Corporation (APIC).

IPEC asks excipient industry to provide insight on elemental impurities

10-Apr-2014 - IPEC Americas has released a standardized letter and template that pharmaceutical companies can use to collect available information from their suppliers regarding elemental impurities in excipients.  

Governments urged to rethink stockpiling after Tamiflu and Relenza reviewed

10-Apr-2014 - Tamiflu shortens the duration of influenza symptoms by only half a day, does not stop person-to-person spread and increases the risk of nausea say the authors of a new review who want Governments to rethink stockpiling neuraminidase inhibitors.

Foreign customers look to US FDA as stamp of quality

09-Apr-2014 - Passing US FDA site inspections is vital to attracting international clients, a European API supplier has said.